Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease
- PMID: 39737997
- PMCID: PMC11686214
- DOI: 10.1038/s41467-024-55062-8
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease
Abstract
Neurodegeneration in Huntington's disease (HD) is accompanied by the aggregation of fragments of the mutant huntingtin protein, a biomarker of disease progression. A particular pathogenic role has been attributed to the aggregation-prone huntingtin exon 1 (HTTex1), generated by aberrant splicing or proteolysis, and containing the expanded polyglutamine (polyQ) segment. Unlike amyloid fibrils from Parkinson's and Alzheimer's diseases, the atomic-level structure of HTTex1 fibrils has remained unknown, limiting diagnostic and treatment efforts. We present and analyze the structure of fibrils formed by polyQ peptides and polyQ-expanded HTTex1 in vitro. Atomic-resolution perspectives are enabled by an integrative analysis and unrestrained all-atom molecular dynamics (MD) simulations incorporating experimental data from electron microscopy (EM), solid-state NMR, and other techniques. Alongside the use of prior data, we report magic angle spinning NMR studies of glutamine residues of the polyQ fibril core and surface, distinguished via hydrogen-deuterium exchange (HDX). Our study provides a molecular understanding of the structure of the core as well as surface of aggregated HTTex1, including the fuzzy coat and polyQ-water interface. The obtained data are discussed in context of their implications for understanding the detection of such aggregates (diagnostics) as well as known biological properties of the fibrils.
© 2024. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures








Update of
-
Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington's disease.bioRxiv [Preprint]. 2024 Sep 15:2023.07.21.549993. doi: 10.1101/2023.07.21.549993. bioRxiv. 2024. Update in: Nat Commun. 2024 Dec 30;15(1):10793. doi: 10.1038/s41467-024-55062-8. PMID: 37502911 Free PMC article. Updated. Preprint.
Similar articles
-
Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington's disease.bioRxiv [Preprint]. 2024 Sep 15:2023.07.21.549993. doi: 10.1101/2023.07.21.549993. bioRxiv. 2024. Update in: Nat Commun. 2024 Dec 30;15(1):10793. doi: 10.1038/s41467-024-55062-8. PMID: 37502911 Free PMC article. Updated. Preprint.
-
Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils.Biochemistry. 2017 Jul 18;56(28):3579-3586. doi: 10.1021/acs.biochem.7b00138. Epub 2017 Jul 7. Biochemistry. 2017. PMID: 28621522 Free PMC article.
-
Concentration-dependent structural transition of huntingtin protein in Huntington's disease.Biophys Chem. 2025 Oct;325:107473. doi: 10.1016/j.bpc.2025.107473. Epub 2025 Jun 4. Biophys Chem. 2025. PMID: 40482382
-
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731. Biochem Soc Trans. 2024. PMID: 38563485 Free PMC article. Review.
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
Cited by
-
Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry.Mol Cell Proteomics. 2025 Jun 20;24(8):101017. doi: 10.1016/j.mcpro.2025.101017. Online ahead of print. Mol Cell Proteomics. 2025. PMID: 40544994 Free PMC article. Review.
-
Pathogenic Proteins Through the Lens of NMR Spectroscopy: Structural and Functional Insights into Disease.Cell Biochem Biophys. 2025 Aug 13. doi: 10.1007/s12013-025-01869-1. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40801977 Review. No abstract available.
-
Multiscale simulations elucidate the mechanism of polyglutamine aggregation and the role of flanking domains in fibril polymorphism.bioRxiv [Preprint]. 2025 May 23:2025.05.19.654960. doi: 10.1101/2025.05.19.654960. bioRxiv. 2025. PMID: 40475647 Free PMC article. Preprint.
-
Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy.J Am Chem Soc. 2025 Jun 25;147(25):21973-21984. doi: 10.1021/jacs.5c05571. Epub 2025 Jun 12. J Am Chem Soc. 2025. PMID: 40505012 Free PMC article.
-
Probing How Anti-huntingtin Antibodies Bind the Fibrillar Fuzzy Coat Using Solid-State NMR.Chemistry. 2025 Aug 13;31(45):e01676. doi: 10.1002/chem.202501676. Epub 2025 Jul 24. Chemistry. 2025. PMID: 40702881 Free PMC article.
References
-
- Ross, C. A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington’s disease and related disorders. Neuron35, 819–822 (2002). - PubMed
-
- Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim.1, 1–21 (2015). - PubMed
-
- DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science277, 1990–1993 (1997). - PubMed
-
- Bäuerlein, F. J. et al. In situ architecture and cellular interactions of polyQ inclusions. Cell171, 179–187 (2017). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical